MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma

Claudia Augello, Valentina Vaira, Luca Caruso, Annarita Destro, Marco Maggioni, Young Nyun Park, Marco Montorsi, Roberto Santambrogio, Massimo Roncalli, Silvano Bosari

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background and aims: Progressive hepatocarcinogenesis is a stepwise process that drives liver transformation. However, the molecular mechanisms of early liver transformation are far from clear. A role for microRNAs (miRNA) as diagnostic and prognostic factors in human tumours, including hepatocellular carcinoma (HCC), is promising. We aimed to identify novel miRNA as biomarkers for differential diagnosis and predictors of disease progression. Methods: We used a low-density array platform to profile the expression of 664 mature miRNA in a cohort of 60 hepatitis C virus-positive liver lesions representative of all stages of progressive hepatocarcinogenesis. We validated selected miRNA in two independent patient series by qPCR and we characterized the genomic status of the miRNA cluster C19MC by fluorescent in situ hybridization and copy-number variation analyses. Results: A 18-miRNA signature distinguished cirrhosis, dysplastic nodules and HCC lesions. Four miRNAs overexpressed in HCCs belonged to chromosome 19 miRNA cluster (C19MC). Significant overexpression of C19MC in early HCC compared to dysplastic nodules could be confirmed in a second series of hepatitis B virus-related liver lesions (n = 30). In a third series of 61 HCCs, C19MC cluster was overexpressed in HCCs compared to matched cirrhotic parenchyma and regardless of the type of viral infection. High C19MC miRNA levels were correlated with poor clinico-pathological features, increased risk of tumour recurrence and shorter overall survival time. HCCs overexpressing the C19MC cluster showed genetic amplification of the corresponding locus. Conclusions: C19MC cluster is a novel molecular alteration characteristic of liver cancer and predictor of poor prognosis. C19MC is an attractive candidate for novel HCC therapies.

Original languageEnglish
Pages (from-to)772-782
Number of pages11
JournalLiver International
Volume32
Issue number5
DOIs
Publication statusPublished - May 2012

Fingerprint

Chromosomes, Human, Pair 19
MicroRNAs
Hepatocellular Carcinoma
Biomarkers
Liver
Virus Diseases

Keywords

  • Chromosome 19 miRNA cluster (C19MC)
  • Cirrhosis
  • Dysplasia
  • Hepatocarcinogenesis
  • Hepatocellular carcinoma
  • MicroRNA

ASJC Scopus subject areas

  • Hepatology

Cite this

MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. / Augello, Claudia; Vaira, Valentina; Caruso, Luca; Destro, Annarita; Maggioni, Marco; Park, Young Nyun; Montorsi, Marco; Santambrogio, Roberto; Roncalli, Massimo; Bosari, Silvano.

In: Liver International, Vol. 32, No. 5, 05.2012, p. 772-782.

Research output: Contribution to journalArticle

@article{a9332285b8cb407ab1984b169c4b0ef6,
title = "MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma",
abstract = "Background and aims: Progressive hepatocarcinogenesis is a stepwise process that drives liver transformation. However, the molecular mechanisms of early liver transformation are far from clear. A role for microRNAs (miRNA) as diagnostic and prognostic factors in human tumours, including hepatocellular carcinoma (HCC), is promising. We aimed to identify novel miRNA as biomarkers for differential diagnosis and predictors of disease progression. Methods: We used a low-density array platform to profile the expression of 664 mature miRNA in a cohort of 60 hepatitis C virus-positive liver lesions representative of all stages of progressive hepatocarcinogenesis. We validated selected miRNA in two independent patient series by qPCR and we characterized the genomic status of the miRNA cluster C19MC by fluorescent in situ hybridization and copy-number variation analyses. Results: A 18-miRNA signature distinguished cirrhosis, dysplastic nodules and HCC lesions. Four miRNAs overexpressed in HCCs belonged to chromosome 19 miRNA cluster (C19MC). Significant overexpression of C19MC in early HCC compared to dysplastic nodules could be confirmed in a second series of hepatitis B virus-related liver lesions (n = 30). In a third series of 61 HCCs, C19MC cluster was overexpressed in HCCs compared to matched cirrhotic parenchyma and regardless of the type of viral infection. High C19MC miRNA levels were correlated with poor clinico-pathological features, increased risk of tumour recurrence and shorter overall survival time. HCCs overexpressing the C19MC cluster showed genetic amplification of the corresponding locus. Conclusions: C19MC cluster is a novel molecular alteration characteristic of liver cancer and predictor of poor prognosis. C19MC is an attractive candidate for novel HCC therapies.",
keywords = "Chromosome 19 miRNA cluster (C19MC), Cirrhosis, Dysplasia, Hepatocarcinogenesis, Hepatocellular carcinoma, MicroRNA",
author = "Claudia Augello and Valentina Vaira and Luca Caruso and Annarita Destro and Marco Maggioni and Park, {Young Nyun} and Marco Montorsi and Roberto Santambrogio and Massimo Roncalli and Silvano Bosari",
year = "2012",
month = "5",
doi = "10.1111/j.1478-3231.2012.02795.x",
language = "English",
volume = "32",
pages = "772--782",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "5",

}

TY - JOUR

T1 - MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma

AU - Augello, Claudia

AU - Vaira, Valentina

AU - Caruso, Luca

AU - Destro, Annarita

AU - Maggioni, Marco

AU - Park, Young Nyun

AU - Montorsi, Marco

AU - Santambrogio, Roberto

AU - Roncalli, Massimo

AU - Bosari, Silvano

PY - 2012/5

Y1 - 2012/5

N2 - Background and aims: Progressive hepatocarcinogenesis is a stepwise process that drives liver transformation. However, the molecular mechanisms of early liver transformation are far from clear. A role for microRNAs (miRNA) as diagnostic and prognostic factors in human tumours, including hepatocellular carcinoma (HCC), is promising. We aimed to identify novel miRNA as biomarkers for differential diagnosis and predictors of disease progression. Methods: We used a low-density array platform to profile the expression of 664 mature miRNA in a cohort of 60 hepatitis C virus-positive liver lesions representative of all stages of progressive hepatocarcinogenesis. We validated selected miRNA in two independent patient series by qPCR and we characterized the genomic status of the miRNA cluster C19MC by fluorescent in situ hybridization and copy-number variation analyses. Results: A 18-miRNA signature distinguished cirrhosis, dysplastic nodules and HCC lesions. Four miRNAs overexpressed in HCCs belonged to chromosome 19 miRNA cluster (C19MC). Significant overexpression of C19MC in early HCC compared to dysplastic nodules could be confirmed in a second series of hepatitis B virus-related liver lesions (n = 30). In a third series of 61 HCCs, C19MC cluster was overexpressed in HCCs compared to matched cirrhotic parenchyma and regardless of the type of viral infection. High C19MC miRNA levels were correlated with poor clinico-pathological features, increased risk of tumour recurrence and shorter overall survival time. HCCs overexpressing the C19MC cluster showed genetic amplification of the corresponding locus. Conclusions: C19MC cluster is a novel molecular alteration characteristic of liver cancer and predictor of poor prognosis. C19MC is an attractive candidate for novel HCC therapies.

AB - Background and aims: Progressive hepatocarcinogenesis is a stepwise process that drives liver transformation. However, the molecular mechanisms of early liver transformation are far from clear. A role for microRNAs (miRNA) as diagnostic and prognostic factors in human tumours, including hepatocellular carcinoma (HCC), is promising. We aimed to identify novel miRNA as biomarkers for differential diagnosis and predictors of disease progression. Methods: We used a low-density array platform to profile the expression of 664 mature miRNA in a cohort of 60 hepatitis C virus-positive liver lesions representative of all stages of progressive hepatocarcinogenesis. We validated selected miRNA in two independent patient series by qPCR and we characterized the genomic status of the miRNA cluster C19MC by fluorescent in situ hybridization and copy-number variation analyses. Results: A 18-miRNA signature distinguished cirrhosis, dysplastic nodules and HCC lesions. Four miRNAs overexpressed in HCCs belonged to chromosome 19 miRNA cluster (C19MC). Significant overexpression of C19MC in early HCC compared to dysplastic nodules could be confirmed in a second series of hepatitis B virus-related liver lesions (n = 30). In a third series of 61 HCCs, C19MC cluster was overexpressed in HCCs compared to matched cirrhotic parenchyma and regardless of the type of viral infection. High C19MC miRNA levels were correlated with poor clinico-pathological features, increased risk of tumour recurrence and shorter overall survival time. HCCs overexpressing the C19MC cluster showed genetic amplification of the corresponding locus. Conclusions: C19MC cluster is a novel molecular alteration characteristic of liver cancer and predictor of poor prognosis. C19MC is an attractive candidate for novel HCC therapies.

KW - Chromosome 19 miRNA cluster (C19MC)

KW - Cirrhosis

KW - Dysplasia

KW - Hepatocarcinogenesis

KW - Hepatocellular carcinoma

KW - MicroRNA

UR - http://www.scopus.com/inward/record.url?scp=84862777528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862777528&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2012.02795.x

DO - 10.1111/j.1478-3231.2012.02795.x

M3 - Article

VL - 32

SP - 772

EP - 782

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 5

ER -